Injective will participate in KBW in Seoul on September 29th. The speaker lineup for the event has not yet been disclosed.
Refer to the official tweet by INJ:
Injective is bringing the new financial era to Seoul during KBW on September 29.
Think LG CNS, Coinbase and SMBC Nikko Securities. As for who’s taking the stage… stay tuned. 👀
Apply to join. Limited spots available. Register below 👇ï¸ pic.twitter.com/JHlm9eESQB
— Injective 🥷 (@injective) September 15, 2026
INJ Info
Injective Protocol is a decentralized exchange (DEX) protocol built on the Cosmos SDK, offering advanced cross-chain trading capabilities.
Key features of Injective Protocol include:
1. Decentralization: On the Injective platform, users have full control over their funds, with no third-party intervention.
2. Cross-chain trading: Injective supports trading between different blockchains, providing users with a wide range of tradable assets.
3. High performance: Injective utilizes the Tendermint consensus system, ensuring high throughput and low transaction latency.
4. Gas-free transactions: Users can trade without the need to pay gas fees.
INJ is the native token of Injective Protocol. The token is used for protocol governance, staking, and participation in voting processes that address key protocol upgrades and management decisions.
